Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when GROW files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Restatement (new) — Company restating Q3 2026 financial statements due to EPS calculation error from spreadsheet formula omission.
- Material Weakness (new) — Material weakness identified in internal controls related to review procedures over weighted average share calculations.
U.S. Global Investors restating Q3 2026 earnings after spreadsheet error overstated EPS
Filed June 2, 2026 · Period ending May 29, 2026 · ~1 min read
Key Changes
-
high
Company overstated Q3 2026 EPS by $0.02 and nine-month EPS by $0.01 due to formula error that excluded 702,484 shares from weighted-average calculation. Net income, revenue, and cash flow unchanged.
Item 4.02 verify on EDGAR → -
high
Management notes it has identified material weaknesses in internal controls over financial reporting in the past and may do so again related to insufficient review procedures for share count calculations. Enhanced controls being implemented.
Item 4.02 verify on EDGAR → -
high
Investors instructed not to rely on original Q3 2026 10-Q filed May 13, 2026, or any related press releases and investor presentations. Amended 10-Q forthcoming.
Item 4.02 verify on EDGAR →
Summary
U.S. Global Investors disclosed a spreadsheet error that overstated earnings per share for the quarter ended March 31, 2026. A formula omission excluded over 700,000 shares from the weighted-average calculation, inflating Q3 EPS by $0.02 and nine-month EPS by $0.01. Importantly, the error affected only per-share metrics—actual net income, revenues, expenses, and cash flows remain unchanged.
The company will file an amended 10-Q to correct the figures. The disclosure reveals a deeper concern: management notes it has identified material weaknesses in internal controls in the past and may do so again, specifically inadequate review procedures for share count calculations. This control failure allowed a basic spreadsheet error to reach published financials.
The company is implementing enhanced review procedures and formula integrity checks to prevent recurrence. Retail investors should watch for the amended 10-Q filing and monitor whether the enhanced controls prove effective in subsequent quarters. While the financial impact is modest, the material weakness designation raises questions about the rigor of the company's financial reporting processes that warrant attention in future filings.
Section-by-Section Diff
Event · Item 4.02 — Non-Reliance on Previously Issued Financial Statements
GROW restating Q3 2026 financials due to EPS calculation error; material weakness in internal controls identified.
Added in current filing · verify on EDGAR →
Any previously furnished reports, press releases, earnings releases, and investor presentations or other communications describing the Company’s consolidated financial statements as of and for the three and nine months ended March 31, 2026, should no longer be relied upon.
The company is instructing investors not to rely on any previously issued financial communications for the three and nine months ended March 31, 2026, including the original 10-Q, press releases, earnings releases, and investor presentations. All such materials will need to be superseded by restated versions.
Event · Item 9.01 — Financial Statements and Exhibits
U.S. Global Investors announces intent to restate EPS for Q1 2026; underlying financial results unchanged.
Added in current filing · verify on EDGAR →
Press Release issued by U.S. Global Investors, Inc. dated June 1, 2026, Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged.
The company announced its intent to restate earnings per share for the quarter ended March 31, 2026. The filing emphasizes that underlying financial results remain unchanged, suggesting the restatement involves a calculation or presentation issue with EPS rather than a change to revenue, expenses, or net income. Investors should await the amended filing for details on the nature of the EPS adjustment.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify